Skip to nav Skip to content


October 30, 2019

 All Issues
 Read the last issue of IDSA News Read the next issue of IDSA News 
IDSA, SHEA, and PIDS to Continue LEAP Fellowship for 2020-2021 Academic Year

IDSA, the Society for Healthcare Epidemiology of America, and the Pediatric Infectious Diseases Society were recently awarded a contract from the Centers for Disease Control and Prevention to continue the Leaders in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship through the 2020-2021 academic year.

Read More
HIVMA Clinical Fellowship Program Now Accepting Applications

The HIVMA Clinical Fellowship Program is accepting applications for the 2020-2021 cycle. 

Read More
IDSA Hosts Research Summit on Outpatient Antimicrobial Stewardship

IDSA hosted a research summit in Washington, DC, on Oct. 29-30, “Leveraging Existing and Novel Diagnostics for Optimizing Outpatient Antimicrobial Stewardship in Patients with Respiratory Tract Infections.” 

Read More
Public Health Concerns Over Immigrant Detention Centers

IDSA and HIVMA members have been raising concerns over the past 18 months about the immigrant detention centers at the U.S.-Mexico border and the vast public health issues they pose. 

Read More
Journal Club

In this feature, a panel of IDSA members identifies and critiques important new studies in the current literature that have a significant impact on the practice of infectious diseases medicine.

Can We Shorten Duration of Therapy for Osteoarticular Infections after Implant Removal?, More Vaccine Options for Herpes Zoster Disease Prevention in the Immunocompromised and CAUTI: Gaps in Knowledge and Practice Styles Related to Urine Cultures

Read More
NIH Human Fetal Tissue Research Policy

IDSA has become increasingly involved in federal discussions regarding recent changes to human fetal tissue research policy, sharing our concerns about the dangers these changes pose to important research and patient care. 

Read More
Supporting VACCINES on Capitol Hill

Vaccine experts gathered earlier this month to speak to congressional staff at a briefing titled “Preventing Outbreaks: Working Together to Increase Vaccine Confidence.”

Read More
To End HIV, Existing Tools and New Interventions Are Needed, NIAID Experts Say

Ending the HIV pandemic will require optimizing existing treatment and prevention tools in addition to continued development of new interventions, experts from the National Institute of Allergy and Infectious Diseases write in a new Viewpoints article published in Clinical Infectious Diseases.

Read More
Tweet Your Support to End HIV as an Epidemic

The Ending the HIV Epidemic Initiative could help communities across the country–but first, Congress needs to pass the 2020 spending bills with funding for the new initiative. 

Read More
Science Speaks Follows the Results of Global Health Commitments, Shortfalls

A little more than a year after the first United Nations high level meeting on TB set measurable milestones toward eliminating the global impacts of the world’s deadliest infectious disease, the World Health Organization’s annual report on tuberculosis incidence, deaths and surveillance showed progress has been promising but uneven. 

Read More
Why Fighting AMR May Be a Hard Sell on Capitol Hill, and more ID in the News

National Journal spoke with Amanda Jezek, IDSA’s senior vice president of public policy and government relations, on why antibiotics are a politically difficult sell on Capitol Hill. 

Read More
ICYMI: What’s Hot on MyIDSA

Here’s a glance at the latest discussions happening on MyIDSA, IDSA’s members-only online community (login required).

Read More

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.